FMP

FMP

Enter

NLTX - Neoleukin Thera...

photo-url-https://financialmodelingprep.com/image-stock/NLTX.png

Neoleukin Therapeutics, Inc.

NLTX

NASDAQ

Inactive Equity

Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. The company's lead product candidate is NL-201, a de novo protein designed to mimic the therapeutic activity of the cytokines interleukin (IL)-2/IL-15 for the treatment of various types of cancer, including renal cell carcinoma and melanoma. The company was formerly known as Aquinox Pharmaceuticals, Inc. and changed its name to Neoleukin Therapeutics, Inc. in August 2019. Neoleukin Therapeutics, Inc. was founded in 2003 and is headquartered in Seattle, Washington.

3.49 USD

0.05 (1.43%)

About

ceo

Ms. Donna M. Cochener-Metcalfe J.D.

sector

Healthcare

industry

Drug Manufacturers - Specialty & Generic

exchange

NASDAQ

Description

Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. The company's lead product candidate is NL-201, a de novo protein designed to mimic the therapeutic activity of the cytokines interleukin (IL)-2/IL-15 for the treatment of various types of cancer, including renal cell carcinoma and melanoma. The company was formerly known as Aquinox Pharmaceuticals, Inc. and changed its name to Neoleukin Therapeutics, Inc. in August 2019. Neoleukin Therapeutics, Inc. was founded in 2003 and is headquartered in Seattle, Washington.

CIK

0001404644

ISIN

US64049K2033

CUSIP

64049K104

Address

188 East Blaine Street

Phone

855 226 6447

Country

US

Employee

7

IPO Date

Mar 7, 2014

NLTX Financial Summary

CIK

0001404644

Exchange

NASDAQ

Industry

Drug Manufacturers -...

Sector

Healthcare

CUSIP

64049K104

ISIN

US64049K2033

Country

US

Price

3.49

Beta

1.1

Volume Avg.

5.52k

Market Cap

8.2M

Shares

-

52-Week

3.42-18.8

DCF

3.6

ROE

-

ROA

-

Operating Margin

-

Debt/Equity

-

P/E

-0.28

P/B

-

Website

https://www.neoleukin.com

Historical Prices

We are unable to load the chart at this time.

fmp-logo

Financial Statement

We are unable to load the chart at this time.

fmp-logo

Earnings

We are unable to load the chart at this time.

fmp-logo

Upgrades and Downgrades

We are unable to load this data!

fmp-logo

People Also Watch

page loading card

Latest NLTX News

It looks like there's no news available.

fmp-logo
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep